Trulicity

Quote
























I would really like to know about the nausea issue. Disclosure: I am not a troll, but someone who works in the GLP-1 field. I do know that all GLP-1 agonists(Byetta, Victoza) cause nausea in some patients. At least with Byetta, this gradually diminishes as the patients develop tolerance to the emetic effect. Trulicity is new and I am wondering if the nausea/vomiting is any worse or prolonged than with say, Byetta or Victoza? I think people working in sales would probably have a very good idea from physician feedback if this is a real concern. Again, not a Novo troll, just someone interested from a scientific standpoint. Thanks
 






Anonymous said:
I would really like to know about the nausea issue. Disclosure: I am not a troll, but someone who works in the GLP-1 field. I do know that all GLP-1 agonists(Byetta, Victoza) cause nausea in some patients. At least with Byetta, this gradually diminishes as the patients develop tolerance to the emetic effect. Trulicity is new and I am wondering if the nausea/vomiting is any worse or prolonged than with say, Byetta or Victoza? I think people working in sales would probably have a very good idea from physician feedback if this is a real concern. Again, not a Novo troll, just someone interested from a scientific standpoint. Thanks
Click to expand...

Ok, AZ troll.
 












Anonymous said:
I would really like to know about the nausea issue. Disclosure: I am not a troll, but someone who works in the GLP-1 field. I do know that all GLP-1 agonists(Byetta, Victoza) cause nausea in some patients. At least with Byetta, this gradually diminishes as the patients develop tolerance to the emetic effect. Trulicity is new and I am wondering if the nausea/vomiting is any worse or prolonged than with say, Byetta or Victoza? I think people working in sales would probably have a very good idea from physician feedback if this is a real concern. Again, not a Novo troll, just someone interested from a scientific standpoint. Thanks
Click to expand...

Yes it's worse.
 






Oh geeee, it only has to include "projectile vomiting" and "retching" on the package insert. Truleeee, my maid will be so pleased after I gorge myself on wings today, and barf it all over.
 










































Another blockbuster! Effient, Strattera, Relprev, Xigris and Amyvid might get jealous! Not to mention all those other 5th line diabetes drugs we push with no market share. Or Axiron we had to pull the plug on. R&D=Nonexistent. Don't need a sales force when you got nothing to sell.
 






Okay, AZ rep who is posting inaccurate comments about Trulicity. This product has the AZ reps running....remember Lilly launched first in class GLP1 so most of us know how to sell a GLP-1 and know the benefits of their product as well as the disadvantages. We were trained on their once weekly before it was pulled from Lilly.

Trulicity may be the FIRST drug Lilly has gotten right in a long time. The Device is amazing and even skeptic endos are impressed...the studies are impressive against Victosa ---they can't speak to that---and finally the patient savings card is in a sample box! What's not to like....

We are BEATING AZ with Tradjenta, Jardiance and soon Trulicity...they all wish they worked here and now they are playing ugly in the field hiding our samples and acting like children.

Lilly Diabetes should be proud....it's the best thing going at Lilly and our portfolio is strong.
Now, we have other issues at Lilly but it certainly isn't Trulicity .....

U200 is coming next....along with combo....we are blowing the others away....let's talk about Sanofi toy looking device they are launching...only your lazy pcp doctors will like it....
 






Anonymous said:
Okay, AZ rep who is posting inaccurate comments about Trulicity. This product has the AZ reps running....remember Lilly launched first in class GLP1 so most of us know how to sell a GLP-1 and know the benefits of their product as well as the disadvantages. We were trained on their once weekly before it was pulled from Lilly.

Trulicity may be the FIRST drug Lilly has gotten right in a long time. The Device is amazing and even skeptic endos are impressed...the studies are impressive against Victosa ---they can't speak to that---and finally the patient savings card is in a sample box! What's not to like....

We are BEATING AZ with Tradjenta, Jardiance and soon Trulicity...they all wish they worked here and now they are playing ugly in the field hiding our samples and acting like children.

Lilly Diabetes should be proud....it's the best thing going at Lilly and our portfolio is strong.
Now, we have other issues at Lilly but it certainly isn't Trulicity .....

U200 is coming next....along with combo....we are blowing the others away....let's talk about Sanofi toy looking device they are launching...only your lazy pcp doctors will like it....
Click to expand...

Are you delusional who wants to work at this dysfunctional shithole, none of the dugs are Lilly's what a Schmuck company no real IQ just a store front.
 












Anonymous said:
Another blockbuster! Effient, Strattera, Relprev, Xigris and Amyvid might get jealous! Not to mention all those other 5th line diabetes drugs we push with no market share. Or Axiron we had to pull the plug on. R&D=Nonexistent. Don't need a sales force when you got nothing to sell.
Click to expand...

What a line up! Those names sound like names of villages of the planet Pandora, BTW
 






Top Bottom
Back
Quote